Dupont Jakob
SEC CIK 1553335 · EDGAR
BoughtSold
Most active insiders at PYXS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dupont Jakob | Dir | — | $107.1K |
| 2 | Wadhane Jitendra | Prin Fin, Acct Off | — | — |
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-02 16:30 | 2026-06-30 | PYXS | Pyxis Oncology, Inc. | Dupont Jakob | Dir | M - OptEx | $1.60 | +35.0K | 73.7K | +90% | +$56.0K |
| DT | 2026-07-02 16:30 | 2026-06-30 | PYXS | Pyxis Oncology, Inc. | Dupont Jakob | Dir | S - Sale+OE | $3.06 | -35.0K | 38.7K | -47% | -$107.1K |
| 2024-03-28 | 2024-03-26 | PYXS | Pyxis Oncology, Inc. | Dupont Jakob | Dir | A - Grant | $0.00 | +38.7K | 38.7K | New | $0 | |
| 2023-03-06 | 2023-03-02 | ATRA | Atara Biotherapeutics, Inc. | Dupont Jakob | EVP, Head of R, D | S - Sale | $3.63 | -5,074 | 290.8K | -2% | -$18.4K | |
| D | 2023-03-03 | 2023-03-01 | ATRA | Atara Biotherapeutics, Inc. | Dupont Jakob | EVP, Head of R, D | A - Grant | $0.00 | +141.3K | 295.9K | +91% | $0 |
| M | 2022-11-18 | 2022-11-16 | ATRA | Atara Biotherapeutics, Inc. | Dupont Jakob | EVP, Head of R, D | S - Sale | $4.49 | -4,342 | 154.5K | -3% | -$19.5K |
| 2022-08-18 | 2022-08-16 | ATRA | Atara Biotherapeutics, Inc. | Dupont Jakob | EVP, Head of R, D | S - Sale | $5.03 | -4,124 | 158.9K | -3% | -$20.7K | |
| 2022-05-19 | 2022-05-17 | ATRA | Atara Biotherapeutics, Inc. | Dupont Jakob | EVP, Head of R, D | S - Sale | $5.32 | -3,873 | 163.0K | -2% | -$20.6K | |
| D | 2022-03-03 | 2022-03-01 | ATRA | Atara Biotherapeutics, Inc. | Dupont Jakob | EVP, Head of R, D | S - Sale | $9.86 | -2,221 | 166.9K | -1% | -$21.9K |
| D | 2022-03-03 | 2022-03-01 | ATRA | Atara Biotherapeutics, Inc. | Dupont Jakob | EVP, Head of R, D | A - Grant | $0.00 | +78.5K | 169.1K | +87% | $0 |
| D | 2022-02-14 | 2022-02-10 | ATRA | Atara Biotherapeutics, Inc. | Dupont Jakob | EVP, Head of R, D | S - Sale+OE | $16.00 | -5,000 | 90.6K | -5% | -$80.0K |
| D | 2022-02-14 | 2022-02-10 | ATRA | Atara Biotherapeutics, Inc. | Dupont Jakob | EVP, Head of R, D | M - OptEx | $9.58 | +5,000 | 95.6K | +6% | +$47.9K |
| D | 2022-01-05 | 2022-01-03 | ATRA | Atara Biotherapeutics, Inc. | Dupont Jakob | EVP, Head of R, D | M - OptEx | $9.58 | +5,000 | 95.6K | +6% | +$47.9K |
| D | 2022-01-05 | 2022-01-03 | ATRA | Atara Biotherapeutics, Inc. | Dupont Jakob | EVP, Head of R, D | S - Sale+OE | $16.01 | -5,000 | 90.6K | -5% | -$80.1K |
| D | 2021-12-03 | 2021-12-01 | ATRA | Atara Biotherapeutics, Inc. | Dupont Jakob | EVP, Head of R, D | M - OptEx | $9.58 | +5,000 | 95.6K | +6% | +$47.9K |
| D | 2021-12-03 | 2021-12-01 | ATRA | Atara Biotherapeutics, Inc. | Dupont Jakob | EVP, Head of R, D | S - Sale+OE | $17.94 | -5,000 | 90.6K | -5% | -$89.7K |
| 2021-11-18 | 2021-11-16 | ATRA | Atara Biotherapeutics, Inc. | Dupont Jakob | EVP, Head of R, D | S - Sale | $17.12 | -2,199 | 90.6K | -2% | -$37.6K | |
| D | 2021-11-04 | 2021-11-02 | ATRA | Atara Biotherapeutics, Inc. | Dupont Jakob | EVP, Head of R, D | S - Sale+OE | $16.41 | -5,000 | 92.8K | -5% | -$82.0K |
| D | 2021-11-04 | 2021-11-02 | ATRA | Atara Biotherapeutics, Inc. | Dupont Jakob | EVP, Head of R, D | M - OptEx | $9.58 | +5,000 | 97.8K | +5% | +$47.9K |
| 2021-08-19 | 2021-08-17 | ATRA | Atara Biotherapeutics, Inc. | Dupont Jakob | EVP, Head of R, D | S - Sale | $12.53 | -2,152 | 92.8K | -2% | -$27.0K |
Purchase Sale Sale after option exercise All abbreviations